As of 2025-07-13, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (31.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.67 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -966.8%.
The range of the Relative Valuation is (30.39) - (30.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 18.5x | 18.4x |
| Forward P/E multiples | 18.6x - 20.7x | 20.5x |
| Fair Price | (30.39) - (30.22) | (31.81) |
| Upside | -928.0% - -923.5% | -966.8% |
| Date | P/E |
| 2025-07-11 | -2.24 |
| 2025-07-10 | -2.31 |
| 2025-07-09 | -2.30 |
| 2025-07-08 | -2.23 |
| 2025-07-07 | -2.23 |
| 2025-07-03 | -2.29 |
| 2025-07-02 | -2.22 |
| 2025-07-01 | -2.20 |
| 2025-06-30 | -2.20 |
| 2025-06-27 | -2.11 |
| 2025-06-26 | -2.16 |
| 2025-06-25 | -2.12 |
| 2025-06-24 | -2.07 |
| 2025-06-23 | -2.03 |
| 2025-06-20 | -1.99 |
| 2025-06-18 | -1.96 |
| 2025-06-17 | -1.96 |
| 2025-06-16 | -1.95 |
| 2025-06-13 | -1.93 |
| 2025-06-12 | -1.96 |
| 2025-06-11 | -1.94 |
| 2025-06-10 | -1.97 |
| 2025-06-09 | -1.96 |
| 2025-06-06 | -1.94 |
| 2025-06-05 | -1.95 |
| 2025-06-04 | -1.97 |
| 2025-06-03 | -1.97 |
| 2025-06-02 | -1.90 |
| 2025-05-30 | -1.82 |
| 2025-05-29 | -1.80 |
| 2025-05-28 | -1.79 |
| 2025-05-27 | -1.80 |
| 2025-05-23 | -1.77 |
| 2025-05-22 | -1.74 |
| 2025-05-21 | -1.72 |
| 2025-05-20 | -1.77 |
| 2025-05-19 | -1.72 |
| 2025-05-16 | -1.68 |
| 2025-05-15 | -1.58 |
| 2025-05-14 | -1.56 |
| 2025-05-13 | -1.61 |
| 2025-05-12 | -1.81 |
| 2025-05-09 | -1.66 |
| 2025-05-08 | -1.69 |
| 2025-05-07 | -1.66 |
| 2025-05-06 | -1.71 |
| 2025-05-05 | -1.81 |
| 2025-05-02 | -1.82 |
| 2025-05-01 | -1.83 |
| 2025-04-30 | -1.80 |